Parameter | Base case estimate | Lowest estimate | Highest estimate | Distribution | Source |
---|---|---|---|---|---|
Discount rate costs (%) | 3.5 | 3 | 5 | – | |
Discount rate health benefits (%) | 3.5 | 1 | 5 | – | |
Sensitivity prototype monitor (%) | 88 | 79 | 94 | Beta | [10] |
Specificity prototype monitor (%) | 99 | 80 | 100 | Beta pert | [10] |
Prior probability of IEEVs (%) | 38 | 10 | 50 | Beta pert | [5] |
Treatment’s effectiveness (%) | 30 | 0 | 50 | – | [Expert opinion] |
ICU survival (%) | |||||
With IEEVs | 63 | 48 | 77 | Beta | Hospital data |
Without IEEVs | 75 | 63 | 84 | Beta | Hospital data |
Hospital survival (%) | |||||
With IEEVs | 41 | 27 | 57 | Beta | Hospital data |
Without IEEVs | 67 | 55 | 77 | Beta | Hospital data |
Hazard ratio of death after ICU admission vs no. admission | 2.01 | 1.64 | 2.46 | Normal | [11] |
Quality of Life (utilities) | |||||
ICU | 0.297 | 0.24 | 0.36 | Beta | Assumed |
Hospital | 0.6 | 0.53 | 0.67 | Beta | [14] |
Year 1 post discharge | 0.67 | 0.62 | 0.71 | Beta | [15] |
Year 2–10 post discharge | 0.70 | 0.65 | 0.75 | Beta | [15] |
Year > 10 post discharge | 0.68 | 0.62 | 0.74 | Beta | [15] |
Resource Use | |||||
ICU LOS (days) | |||||
With IEEVs | 28 | 23 | 34 | Gamma | Hospital data |
Without IEEVs | 22 | 18 | 27 | Gamma | Hospital data |
Time on MV (days) | |||||
With IEEVs | 21 | 17 | 27 | Gamma | Hospital data |
Without IEEVs | 15 | 12 | 17 | Gamma | Hospital data |
Hospital LOS post-ICU discharge (days) | 17.3 | 14 | 21 | Gamma | [20] |
Unit costs (in 2019 Euros) | |||||
Analytics licensing (per bed, per year) | 1918 | 100 | 20,000 | – | [16] |
Treatment | 100 | 57 | 155 | Gamma | [Expert opinion] |
ICU day | 686 | 392 | 1060 | Gamma | [17] |
Hospital day | 298 | 170 | 460 | Gamma | [18] |
Reduction in ICU costs when patients no longer receive MV (%) | 10 | 0 | 35 | Beta pert | [Expert opinion] |